Troy Edward Wilson sold $327K of Kura Oncology (KURA)

Executed Sep 29 2025, disclosed Sep 29 2025, the same day.

Value, as filed

$327K

36,615 sh × $8.94

Executed

Sep 29 2025

the trade date, as filed

Disclosed

Sep 29 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TW Troy Edward Wilson President and CEO profile →

Troy Edward Wilson (President and CEO) filed 3 Form 4 reports in the trailing twelve months (2 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). Across 1 priced purchase filing, the average 21-session return was +3.2% from execution and +3.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of KURA (100,000 sh × $12.39, as filed), executed Aug 24.

The name

KURA Kura Oncology, Inc. KURA · Healthcare · 13 filings in 24 months ticker →

Healthcare · Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Troy Edward Wilson in KURA

KURAPURCHASE Kura Oncology, Inc. $1.2M
100,000 sh × $12.39
Exec Aug 24
Filed Aug 24 · 5:30 PM ET KURAPURCHASE Kura Oncology, Inc. $1.1M
100,000 sh × $11.12
Exec Aug 17
Filed Aug 17 · 4:45 PM ET KURAPURCHASE Kura Oncology, Inc. $410K
50,000 sh × $8.20
Exec Sep 8 2025
Filed Sep 9 2025 · 4:28 PM ET KURAPURCHASE Kura Oncology, Inc. $214K
36,506 sh × $5.85
Exec Aug 12 2025
Filed Aug 14 2025 · 4:05 PM ET